IVF and Fertility Laboratory, Department of Obstetrics and Gynecology, Bikur Cholim Hospital, 5 Strauss St., Jerusalem 91004, Israel
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: follicle development/GnRH agonist/ICSI
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The formation of ovarian cysts following pituitary down-regulation is considered detrimental. Thus, in many cases IVF cycles are cancelled or cysts are aspirated to discontinue their functional activity (
Feldberg et al.1988;
Rizk et al.1990
;
Silverberg et al.1990
;
Jenkins et al.1992
;
Ellenbogen et al.1997
).
In this case report we present a woman with impaired ovarian function, who developed an oocyte-containing cyst upon GnRH agonist administration. Following the use of HCG and ICSI, a successful pregnancy was established.
![]() |
Case Report |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Three years previously, an IVF treatment (14 oocytes retrieved, 50% fertilization) combined with zygote intra- Fallopian transfer had resulted in a pregnancy and the birth of a healthy boy weighing 2970 g. During the last 2 years, two IVF cycles were attempted (23 and 18 oocytes were achieved with 48% and 39% fertilization rates respectively), but the woman did not conceive. On day 21 of the menstrual cycle preceding her treatment cycle, oestradiol and progesterone concentrations were 200 pmol/l and 1.9 nmol/l respectively. Transvaginal sonography revealed small follicles and GnRH agonist (Decapeptyl CR 3.75 mg; Ferring, Kiel, Germany) was initiated. Eleven days later, oestradiol and progesterone concentrations were 5276 pmol/l and 3.0 nmol/l, respectively. Sonography revealed seven follicle-cysts (2.02.4 cm in diameter) and the endometrial thickness was 6 mm. The woman expressed her wish to have the cysts aspirated in order to advance her treatment. She agreed to our suggestion to attempt HCG administration in case the follicles contained oocytes. HCG (10000 IU; Chorigon, Teva, Kfar Savah, Israel) was administered and 36 h later the follicle-cysts were aspirated. The aspirates were examined and a single oocyte was retrieved. Because the husband had a low concentration of motile sperm (a total of 0.8x106 spermatozoa with poor motility ) and because we were concerned that IVF insemination of a single oocyte might result in failed fertilization, ICSI was performed. We suggested to our patient the option of freezing the single embryo for a later transfer along with other fresh or frozen embryos but the women preferred to complete the treatment. After ~48 h a 4-cell embryo was transferred into the uterus. On the day of embryo transfer endometrial thickness was 9 mm and serum oestradiol and progesterone concentrations were 1402 pmol/l and >130 nmol/l respectively. Daily injections of 100 mg i.m. progesterone (Geston; Pains and Byrne, Surrey, UK) were provided for luteal phase support. The woman conceived and a healthy baby boy weighing 2800 g was born at 36 weeks of gestation.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
It seems that the GnRH agonist did not impair oocyte quality and endometrial receptivity because normal fertilization was enabled and embryo implantation was successful. The inhibitory effect of GnRH agonist on corpus luteum activity was overcome by progesterone administration.
The procedure presented in this report may be considered as a treatment option when follicle-cysts to be aspirated are accompanied by a significant rise in circulating oestradiol concentrations. However, the practice is suboptimal because the oocyte yield might be low, thus affecting the final outcome of the treatment. Being aware of the large resources required to complete an IVF cycle, we suggest that this procedure should be applied in carefully selected cases and combined with the option of embryo cryopreservation.
![]() |
Notes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ellenbogen, A., Abu-Asbah, I., Libal, Y. et al. (1997) The behavior of follicle cysts formed after long- acting gonadotrophin releasing hormone analog administration in patients with polycystic ovarian syndrome. Gynecol. Endocrinology, 11,101104.[ISI][Medline]
Feldberg, D., Ashkenazi, J., Dicker, D. et al. (1988) Ovarian cyst aspiration during IVF/ET cycles. J. In Vitro Fert. Embryo Trans., 5, 372375.[ISI][Medline]
Feldberg, D, Ashkenazi, J., Dicker, D. et al. (1989) Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy. Fertil. Steril., 51, 4245.[ISI][Medline]
Jenkins, J.M., Davies, D.W., Anthony, F.W. et al. (1992) The detrimental influence of functional ovarian cysts during in vitro fertilization cycles. Hum. Reprod., 7, 776780.[Abstract]
Jenkins, J.M. (1996) The influence, development and management of functional ovarian cysts during IVF cycles. Hum. Reprod., 11, (Suppl.), 132136.[ISI]
Lockwwood, G.M., Pinkerton, S.M., and Barlow, D.H. (1995) A prospective randomized single- blind comparative trial of nafarelin acetate with buserelin in long protocol gonadotrophin-releasing hormone analogue controlled in vitro fertilization cycles. Hum. Reprod., 10, 293298.[Abstract]
Mehta, R.H. and Anand Kumar, T.C. (2000) Can GnRH agonists act directly on the ovary and contribute to cyst formation? Hum. Reprod., 15, 505507.
Rizk, B., Steer, C., Tan, S.L. et al. (1990) Ovarian cyst aspiration and the outcome of in vitro fertilization. Fertil. Steril., 54, 661664.[ISI][Medline]
Ron El, R., Raziel, A., Herman, A. et al. (1989) Follicle cyst formation following long acting gonadotropin releasing hormone analogue administration. Fertil. Steril., 52, 10631066.[ISI][Medline]
Silverberg, K.M., Olive, D.L. and Schenken, R.S. (1990) Ovarian cyst aspiration prior to initiating ovarian hyperstimulation for in vitro fertilization. J. In Vitro Fertil. Embryo Trans., 7, 153156.
Submitted on December 20, 2000; accepted on April 19, 2001.